Market Updates

General Mills Licenses Microencapsulation Technology to Martek

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

To alleviate some challenges in formulating DHA-fortified foods, Martek Biosciences Corporation, Columbia, MD, and General Mills, Minneapolis, MN, have entered a license agreement for a pa­tented microencapsulation technology. Microencapsulation protects the integrity of food ingredients and helps maintain the nutritional value, shelf-life and flavor of the finished food or beverage product. Developed by General Mills, this new patented technology will likely enhance Martek’s ability to produce high-quality, cost-effective DHA powders for certain food applications—particularly long shelf-life products and applications with sensory and formulation challenges. Under the terms of the agreement, Martek is granted a perpetual and generally exclusive license, with respect to third parties, to the General Mills technology for use with DHA and other polyunsaturated fatty acids. General Mills retains the right to this technology for its own use and exclusively for all uses within some of its core businesses.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters